OncoSwab

Private

CourrouxHealthcare & Life Scienceshttps://oncoswab.com/

Last Round

Grant

May 5, 2025

Total Funding Raised

$4.2M

Company Overview

OncoSwab is a biotechnology company developing a non-invasive, nasal swab-based diagnostic platform for the early detection of lung cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

lung cancer screeningnasal swabliquid biopsylaboratory developed testLDTgenomic biomarkersnon-invasive diagnosticsearly cancer detectionpulmonary noduleAI diagnosticsprecision medicinectDNAbiotech startupresearch use onlyRUO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoSwab Comps

Public and private peers based on sector, stage, and business model.

OncoSwab comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OncoSwab Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	May 5, 2025
Pre Seed	Oct 25, 2024
Pre Seed	Mar 12, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Andrea Stephany Diaz

Co-Founder CEO

Founding Team

OncoSwab Investors

Notable investors and investment history

OncoSwab investors
Investor	Rounds
Switzerland Innovation	Pre Seed
Basel Area Business & Innovation	Pre Seed
European Institute of Innovation and Technology	Pre Seed
University of Toronto	Pre Seed
Creative Destruction Lab	Pre Seed
DayOne	Pre Seed
Innosuisse	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 5, 2025
Secured $1.58M in grant funding.

View all signals

OncoSwab Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

OncoSwab Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoSwab's valuation, stock price, and market status.

Firmographic Details

HeadquartersCourroux

Employee Range7

Year Founded2023

Last FundingMay 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.